International Comparative Analysis and Explanation in Medical Sociology: Demystifying the Halcion Anomaly
Authors:
- John AbrahamJAJohn Abraham
- Julie SheppardJSJulie Sheppard
- 1 February 1998
- journal article
- research article
- Published by SAGE Publications in Sociology
- Vol. 32 (1) , 141-162
Abstract
The US drug regulatory authority, the Food and Drug Administration (FDA) is often thought to demand higher standards of consumer protection from drug manufacturers than its British counterparts, the Medicines Control Agency (MCA) and the Committee on the Safety of Medicines (CSM). Yet since 1991 the MCA has banned one of the most prescribed tranquillisers, Halcion, while it remains approved by the FDA and on the market in the United States. This article attempts to explain the Halcion anomaly and questions explanations proposed by previous sociological research in the field. Broad societal influences, such as the role of the mass media, the increasing threat of litigation regarding drug injury and deregulatory politics are considered to be unlikely explanations. Rather, microsociological processes concerning the internal organisation of the drug regulatory authorities and the interaction between that organisation and technical analyses of safety data are found to be the key explanatory factors.Keywords
This publication has 11 references indexed in Scilit:
- The Failure of Nuclear Power2000
- Halcion Nights: A Sociological Account of a Medical ControversySociology, 1996
- Negotiation and accommodation in expert medical risk assessment and regulation: An institutional analysis of the benoxaprofen casePolicy Sciences, 1994
- Scientific Standards and Institutional Interests: Carcinogenic Risk Assessment of Benoxaprofen in the UK and USSocial Studies of Science, 1993
- Vitamin C and Cancer: Medicine or Politics?1991
- Media Discourse and the Social Construction of RiskSocial Problems, 1990
- Regulating Risk: Implications of the Challenger Accident*Law & Policy, 1989
- Food additive controlsFood Policy, 1989
- The Estrogen Replacement Controversy in the USA and UK: Different Answers to the Same Question?Social Studies of Science, 1984
- Carcinogenic Risk Assessment in the United States and Great Britain: The Case of Aldrin/DieldrinSocial Studies of Science, 1979